Richard_Fleming summary.md 1.5 KB

Richard Fleming Notes

Antibiotic Bacterial Resistance

  • Strains which survive antibiotic use are resistant
  • We are doing similarly with vaccination

The Spike

  • Code being produced is for SARS-CoV Wuhan HU1
  • Nucleotide sequences don't perfectly match HU1

Immune Layers

  • Innate
  • Macrophage eats virus and presents
  • Naive T cells react to become T-helper 1 and T-helper 2
  • TH-1 cytotoxic which kill infected cell
  • TH-2 effector which induces creation/updating of B cell

Skipping Step

The mRNA vaccines don't seem to induce differentiation of T-helper 2 cells.

  • Possibly because the virus is not seen outside of cells.
  • Nanolipid particle technique bypasses this
  • Blunted interferon response

EUA Documents

  • Don't show the cell differentiation statistics
  • Only show recording of symptoms / illness

Diminishing natural immunity

  • Taking the mRNA shots causes reduced response to other non-CoV pathogens

Biodistribution

  • Moderna 2017 did nanolipid influenza study and discovered that it spread to brain and bone marrow etc.
  • Lipid nanoparticles great way to get into cells - merge with cell wall

Immune research

  • Research on immunity has always favoured Ab response. T cell assays are complicated, require more training, more expensive reagents/equipment, etc.
  • hampered immune response might mean require higher Ab counts

Spike load

  • Person to person transmission means exposure to 100s - 10000 spikes
  • Pfizer/Moderna 13.1 billion codes?
  • AZ/Jannsen 50 billion